Tsai Ching-Yi, Poon Yan-Yuen, Huang Ya-Hui, Chan Samuel Hh
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan,
Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
J Pain Res. 2018 Nov 1;11:2699-2708. doi: 10.2147/JPR.S175259. eCollection 2018.
The nociceptin receptor (NOP) was discovered in 1994 and was designated opioid-like receptor; activation of NOP leads to reduced neuronal excitability. Although suggested by the anatomical localization of NOP in brain or spinal cord, the cardiovascular or nociceptive effects of its endogenous ligand, nociceptin, are equivocal. Taking advantage from intrathecal application of nociceptin to simultaneously activate NOP on sympathetic preganglionic neurons in the intermediolateral column (IML) and superficial laminae of dorsal horn, we investigated whether the nociceptin-induced cardiovascular effects engage the participation of baroreflex, and whether the concurrently elicited changes in blood pressure and pain responses are interrelated.
NOPs in the thoracic spinal cord of ICR or C57BL/6 mice were identified with immunofluorescence staining and were activated through intrathecal administration of nocicetpin. The elicited changes in cardiovascular parameters and tail-flick nociceptive responses were measured.
Positive immunoreactivity against NOP colocalized with neurons in the IML and superficial dorsal horn layers of thoracic spinal cord. Intrathecal administration of nociceptin (1, 2, or 5 nmol) elicited a significant and dose-dependent decrease in blood pressure or heart rate that was paralleled by reduced baroreflex-mediated sympathetic vasomotor tone and mirrored by augmented cardiac vagal baroreflex, alongside prolonged tail-flick latency with an efficacy of hypotension <<< antinociception. Coadministration of the specific NOP antagonist, UFP101 (10 nmol), blunted all nociceptin-elicited responses. However, restoring blood pressure to baseline level failed to affect the antinociceptive actions of nociceptin.
Activation of thoracic spinal NOP in ICR and C57BL/6 mice induces blood pressure and heart rate by decreasing the sympathetic outflow of both arms of the baroreflex arc to the blood vessels and the heart, and the antinociceptive responses to nociceptin are independent of and disproportional to its cardiovascular actions.
痛敏肽受体(NOP)于1994年被发现,并被命名为阿片样受体;NOP的激活会导致神经元兴奋性降低。尽管从NOP在脑或脊髓中的解剖定位来看有此推测,但其内源性配体痛敏肽对心血管或伤害性感受的影响并不明确。利用鞘内注射痛敏肽同时激活中间外侧柱(IML)交感神经节前神经元和背角浅层的NOP,我们研究了痛敏肽诱导的心血管效应是否涉及压力反射的参与,以及同时引发的血压变化和疼痛反应是否相互关联。
通过免疫荧光染色鉴定ICR或C57BL/6小鼠胸段脊髓中的NOP,并通过鞘内注射痛敏肽激活这些受体。测量引发的心血管参数变化和甩尾伤害性反应。
针对NOP的阳性免疫反应与胸段脊髓IML和背角浅层的神经元共定位。鞘内注射痛敏肽(1、2或5 nmol)会引起血压或心率显著且剂量依赖性降低,同时压力反射介导的交感血管运动张力降低,心脏迷走神经压力反射增强,甩尾潜伏期延长,且降压效果 <<< 抗伤害感受效果。共同注射特异性NOP拮抗剂UFP101(10 nmol)可减弱所有痛敏肽引发的反应。然而,将血压恢复到基线水平并不能影响痛敏肽的抗伤害感受作用。
在ICR和C57BL/6小鼠中激活胸段脊髓NOP通过减少压力反射弧双臂向血管和心脏的交感神经输出,从而诱导血压和心率变化,并且痛敏肽的抗伤害感受反应与其心血管作用无关且不成比例。